Assessment of Selective and Universal Screening for Suicide Risk in a Pediatric Emergency Department.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 10 2019
Historique:
entrez: 26 10 2019
pubmed: 28 10 2019
medline: 17 6 2020
Statut: epublish

Résumé

According to National Patient Safety Goal 15.01.01, all individuals being treated or evaluated for behavioral health conditions as their primary reason for care in hospitals and behavioral health care organizations accredited by The Joint Commission should be screened for suicide risk using a validated tool. Existing suicide risk screens have minimal or no high-quality evidence of association with future suicide-related outcomes. To test the association between results of the Ask Suicide-Screening Questions (ASQ) instrument in a pediatric emergency department (ED), implemented through selective and universal screening approaches, and subsequent suicide-related outcomes. In this retrospective cohort study at an urban pediatric ED in the United States, the ASQ was administered to youths aged 8 to 18 years with behavioral and psychiatric presenting problems from March 18, 2013, to December 31, 2016 (selective condition), and then to youths aged 10 to 18 years with medical presenting problems (in addition to those aged 8-18 years with behavioral and psychiatric presenting problems) from January 1, 2017, to December 31, 2018 (universal condition). Positive ASQ screen at baseline ED visit. The main outcomes were subsequent ED visits with suicide-related presenting problems (ie, ideation or attempts) based on electronic health records and death by suicide identified through state medical examiner records. Association with suicide-related outcomes was calculated over the entire study period using survival analyses and at 3-month follow-up for both conditions using relative risk. The complete sample was 15 003 youths (7044 [47.0%] male; 10 209 [68.0%] black; mean [SD] age, 14.5 [3.1] years at baseline). The follow-up for the selective condition was a mean (SD) of 1133.7 (433.3) days; for the universal condition, it was 366.2 (209.2) days. In the selective condition, there were 275 suicide-related ED visits and 3 deaths by suicide. In the universal condition, there were 118 suicide-related ED visits and no deaths during the follow-up period. Adjusting for demographic characteristics and baseline presenting problem, positive ASQ screens were associated with greater risk of suicide-related outcomes among both the universal sample (hazard ratio, 6.8 [95% CI, 4.2-11.1]) and the selective sample (hazard ratio, 4.8 [95% CI, 3.5-6.5]). Positive results of both selective and universal screening for suicide risk in pediatric EDs appear to be associated with subsequent suicidal behavior. Screening may be a particularly effective way to detect suicide risk among those who did not present with ideation or attempt. Future studies should examine the impact of screening in combination with other policies and procedures aimed at reducing suicide risk.

Identifiants

pubmed: 31651971
pii: 2753525
doi: 10.1001/jamanetworkopen.2019.14070
pmc: PMC6822088
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1914070

Références

Psychiatr Serv. 2001 Jun;52(6):828-33
pubmed: 11376235
Pediatr Emerg Care. 1994 Feb;10(1):6-12
pubmed: 8177812
NCHS Data Brief. 2018 Nov;(330):1-8
pubmed: 30500324
BMJ. 1999 May 8;318(7193):1235-9
pubmed: 10231250
Am J Public Health. 2013 May;103(5):822-9
pubmed: 23488515
Bull World Health Organ. 2008 Sep;86(9):703-9
pubmed: 18797646
Sentinel Event Alert. 2016 Feb 24;(56):1-7
pubmed: 26915165
Arch Pediatr Adolesc Med. 2012 Dec;166(12):1170-6
pubmed: 23027429
Br J Psychiatry. 2007 Dec;191:548-53
pubmed: 18055960
PLoS One. 2016 Jun 10;11(6):e0156322
pubmed: 27285387
World Psychiatry. 2015 Feb;14(1):36-42
pubmed: 25655149
JAMA Pediatr. 2015 Jul;169(7):673-7
pubmed: 25984947
Hosp Pediatr. 2019 Apr;9(4):305-307
pubmed: 30858170
BMJ. 2006 May 27;332(7552):1241-5
pubmed: 16735333
JAMA. 2014 Mar 19;311(11):1107-8
pubmed: 24515285
JAMA Psychiatry. 2016 Nov 01;73(11):1119-1126
pubmed: 27654151
BMJ. 2005 Oct 8;331(7520):805
pubmed: 16183654
Pediatr Emerg Care. 2007 Jun;23(6):387-93
pubmed: 17572523
Prev Sci. 2017 Feb;18(2):174-182
pubmed: 27678381
Arch Gen Psychiatry. 1972 May;26(5):399-404
pubmed: 5019875
Curr Opin Pediatr. 2009 Oct;21(5):620-7
pubmed: 19617829
Am J Prev Med. 2016 Apr;50(4):445-453
pubmed: 26654691

Auteurs

Jordan E DeVylder (JE)

Graduate School of Social Service, Fordham University, New York, New York.

Taylor C Ryan (TC)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Mary Cwik (M)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.

Mary Ellen Wilson (ME)

Division of Pediatric Emergency Medicine, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Samantha Jay (S)

Department of Psychology, University of Maryland Baltimore County, Baltimore.

Paul S Nestadt (PS)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.

Mitchell Goldstein (M)

Division of Pediatric Emergency Medicine, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Holly C Wilcox (HC)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH